Advanced Search

 

Study ID Status Title Patient Level Data
116794 Recruiting Inner-City Asthma School Program - “Building Bridges: Advancing Education by Improving Asthma Management in Inner-City Children”
116796 Completed Immunogenicity and safety of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults with a prior episode of herpes zoster Study Listed on ClinicalStudyDataRequest.com
116797 Completed An open-label, randomized, single dose, three-way crossover study to determine the comparative bioavailability of two fixed dose combination tablet formulations of amlodipine (5mg) and losartan (100mg) in healthy adult male and female Subjects under fasting conditions Study Listed on ClinicalStudyDataRequest.com
116798 Completed An Open-Label, Randomized, Single Dose, Two-Way Crossover Pilot Study to Evaluate the Relative Bioavailability of One Amlodipine 5 mg Tablet and One Enalapril Maleate 20mg Tablet to a Fixed Dose Combination Tablet Formulation of Amlodipine (5 mg) and Enalapril Maleate (20 mg), in Healthy Adult Male and Female Subjects under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
116799 Completed An open-label, randomised, single dose, three-way crossover, parallel groups study to determine the bioequivalence of two fixed dose combination (FDC) tablet formulations of amlodipine and losartan FDC5/50 and FDC5/100 to respective reference dosages in healthy adult male and female subjects under fasting conditions Study Listed on ClinicalStudyDataRequest.com
116804 Completed Seroprevalence of Bordetella pertussis in adults in Hungary
116805 Completed Indirect comparison lapatinib+capecitabine vs trastuzumab+capecitabine in metastic breast cancer
116806 Terminated An Open-Label, Randomized, Single Dose, Four-way Crossover, Multi-stage Study to determine the Comparative Bioavailability of two fixed dose combination tablet formulations, 500 mg or 1000 mg extended release metformin and 1 mg or 2 mg extended release glimepiride, in healthy adult male and female subjects in the fed state Study Listed on ClinicalStudyDataRequest.com
116811 Completed Long-term persistence of immunity to hepatitis B in adults vaccinated 20 to 30 years ago with Engerix™-B (NCT01627340)
116815 Completed A Single-Center Randomized, Open-Label, Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 LAP in Healthy Adult Subjects.
116827 Completed Bioequivalence study between two medications for the oral administration of terbinafine 250 mg in oral solids in healthy volunteers
116828 Terminated Study IVF116828:A Multi-Cohort Phase I Study to Investigate the Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban (GSK557296) in Healthy Female Volunteers During Control and Challenge States With and Without Oxytocin
116829 Completed Clinical and cost impact of complete and incomplete rotavirus vaccination
116830 Completed Clinical and cost impact of complete and incomplete Rotarix vaccination
116831 Completed A retrospective database analysis of clinical outcomes in BPH patients treated with 5‑alpha reductase inhibitors in the Netherlands.
116833 Active, Not Recruiting An Open-Label, Four-Part, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of the MEK Inhibitor GSK1120212, BRAF Inhibitor GSK2118436 and the anti-EGFR Antibody Panitumumab in Combination in Subjects with BRAF-mutation V600E Positive Colorectal Cancer and in Subjects with CRC With Secondary Resistance to Prior Anti-EGFR Therapy
116844 Completed Meta-Analysis Results Report for DB2116844: Meta-analysis of DB2113360 and DB2113374: an Integrated Review of Transition Dyspnoea Index data for Umeclidinium/Vilanterol, Umeclidinium, Vilanterol and Tiotropium over 24 Weeks in Subjects with COPD
116849 Active, not recruiting A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects with Varying Degrees of Renal Impairment and in Matched Control Subjects with Normal Renal Function
116850 Completed Bioequivalence study between two medications for administration of Oral Gabapentin in 300 mg capsules in healthy volunteers
116853 Completed A Phase III, 24 Week, Randomized, Double Blind, Double Dummy, Parallel Group Study (with an Extension to 52 Weeks in a Subset of Subjects) Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination FF/UMEC/VI Administered Once Daily in the Morning via a Dry Powder Inhaler with Budesonide/Formoterol 400mcg/12mcg Administered Twice-Daily via a Reservoir Inhaler in Subjects with Chronic Obstructive Pulmonary Disease
116855 Active, not recruiting A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease
116859 Completed Flolan® Article 81, a retrospective observational study of the cohort of pulmonary arterial hypertension patients treated by Expert Centres in Belgium with Flolan® (epoprostenol).Flolan® is a registered trademark of the GlaxoSmithKline group of companies.
116861 Completed Safety and tolerability of GSK 1557484A vaccine in adults at occupational risk for influenza A (H5N1) exposure
116863 Completed A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticasone Furoate 100 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents Study Listed on ClinicalStudyDataRequest.com
116878 Terminated Study PTG116878, a Dose-Optimization Study of Ezogabine/Retigabine Immediate Release Tablets versus Placebo in the Adjunctive Treatment of Subjects with Partial-Onset Seizures Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.